# BioReason v0.2 Foundation Report (Phase 3 Increment 1)

**Execution Date**: 2026-09-15  
**Final Project Verdict**: `V0_2_FOUNDATION_READY`  
**Automated Tests**: 39 / 39 Passing (100% Green)  

---

## 1. Executive Summary

BioReason v0.1 development and its one-time locked final evaluation are complete and permanently frozen. 

In accordance with Phase 3 specifications, **BioReason v0.2 development has been initialized**. The central goal of v0.2 is to determine whether BioReason's learned scientific reasoning transfers to **new biological domains, new experimental assay structures, real-world scientific literature, and independently authored methodological problems**.

This foundation phase establishes:
1. Complete architectural and topological schemas (`ExperimentGraph`).
2. Multi-modal contamination prevention (`ContaminationEngineV4`).
3. Formal human review standards (`SCIENTIFIC_REVIEW_PROTOCOL.md`).
4. Core scientific invariants (`SCIENTIFIC_INVARIANTS.md`).
5. External validation and blind peer review plan (`EXTERNAL_VALIDATION_PLAN.md`).
6. Initial pilot datasets (100 newly authored cases across 16+ biological domains with zero contamination).
7. Clean automated test suite expansion (39/39 passing).

---

## 2. BioReason v0.1 Frozen Release State

| Component | Frozen State / Checkpoint | Notes |
| :--- | :--- | :--- |
| **Base Model** | `Qwen/Qwen2.5-14B-Instruct` | 14.7B parameters, 32k context |
| **Selected SFT Checkpoint** | `BR-SFT-001-A` Epoch 2.0 | `outputs/BR-SFT-001-A/checkpoint-epoch-2.0` |
| **Selected DPO Checkpoint** | `BR-DPO-002-A` | `outputs/BR-DPO-002-A/checkpoint-100pct` |
| **Release Status** | `SCIENTIST_BETA` | Research use only; no clinical/diagnostic use |
| **Project Verdict** | `BIOREASON_V0_1_VALIDATED` | One-time locked evaluation completed |
| **Generalization Verdict** | `STRONG_GENERALIZATION` | Transfer from dev benchmark to held-out test |
| **Locked Final Benchmark** | `CONSUMED_FOR_V0_1_FINAL_EVALUATION` | 51 items; permanently retired from future testing |

---

## 3. Schema & Architectural Innovations in v0.2

### 3.1 `ExperimentGraph` Topological Representation
Located in `src/bioreason/schemas/experiment_graph.py`, `ExperimentGraph` introduces a formal DAG representation of biological experiments:

```
[Subject Node] ──(DERIVED_FROM)──► [Sample Node] ──(MEASURED_AT)──► [Observation Node]
       │                                                                  │
  (SPLIT_INTO)                                                       (ASSIGNED_TO)
       ▼                                                                  ▼
[Train Partition] ◄──(TRAINED_ON)── [Model Node] ◄──(TRANSFORMED_BY)── [Transformation]
```

- **Topological Invariant Checking**:
  - `check_partition_leakage()`: Automatically flags transformations, scalers, or feature selections that ingest observations from both training and test partitions.
  - `check_pseudoreplication_topology()`: Automatically flags instances where subordinate observations from a single biological subject are split across train and test partitions.
  - `compute_structural_fingerprint()`: Generates a SHA-256 graph invariant signature for cross-study structural comparison.

### 3.2 Contamination Engine V4
Located in `src/bioreason/datasets/contamination_v4.py`, Contamination Engine V4 provides an 8-layer multi-modal firewall:
1. Exact string matching
2. Normalized text matching
3. Token & N-gram Jaccard similarity
4. ScenarioSignature collision detection
5. Subword & TF-IDF Cosine Semantic Similarity
6. Study-Structure fingerprinting (assay, design, unit hierarchy, objective, failure type)
7. Source-Document Provenance & Citation/DOI/URL Overlap Detection
8. ExperimentGraph Structural Topology Fingerprint Matching

---

## 4. Newly Authored Datasets & Scientific Coverage

A total of **100 new, independently authored cases** were generated, schema-validated, and audited:

### 4.1 Dataset Summary

| Dataset Partition | File Location | Count | Schema Validation | Review Tier |
| :--- | :--- | :--- | :--- | :--- |
| **BioReasonBench-v0.2 Pilot** | `benchmark/v0.2/bioreason_bench_v0_2_pilot.json` | 25 | `BenchmarkItem` | 100% `EXPERT_VALIDATED` |
| **BioReasonChallenge-v0.1** | `challenge/bioreason_challenge_v0.1/bioreason_challenge_v0_1.json` | 25 | JSON Schema | 100% `BENCHMARK_VERIFIED` |
| **BioReasonTrain-v0.2 Pilot** | `training_data/v0.2/candidate_episodes_v0_2_pilot.json` | 50 | `ScientificReasoningEpisode` | 48% `TIER_A`, 52% `TIER_B` |

### 4.2 Broad Domain Expansion (16+ Distinct Areas)
1. **Spatial Transcriptomics & In Situ Imaging**: 10x Visium, MERFISH, spatial autocorrelation leakage.
2. **Epigenomics & Chromatin Accessibility**: ATAC-seq peak calling leakage, ChIP-seq input controls, CUT&Tag aliquot pseudoreplication, DNA methylation 850k array PCA leakage.
3. **Proteomics & Metabolomics**: LC-MS/MS, TMT 10-plex reference channels, Missing Not At Random (MNAR) left-censored imputation, mass spec run-order drift.
4. **Microbiome Sequencing**: 16S rRNA relative abundance compositionality artifacts, Centered Log-Ratio (CLR) transformations, SparCC.
5. **Functional Genomics & CRISPR Screens**: Genome-wide pooled sgRNA screens, FACS sorting bottleneck drop-out, CERES/Chronos copy-number bias.
6. **Long-Read Sequencing & Population Genomics**: Oxford Nanopore homopolymer indel calling, GWAS population stratification ancestry confounding, LD Score Regression.
7. **Clinical Cohorts & Survival Modeling**: Right-censoring selection bias, immortal time bias, Cox proportional hazards with Schoenfeld residuals.
8. **Longitudinal Omics**: Serial biopsies, within-subject repeated measures autocorrelation, linear mixed-effects modeling.
9. **Biological Machine Learning**: Subtle SMOTE / ADASYN resampling leakage across splits, GroupKFold patient isolation, gene homology split leakage in variant interpretation.
10. **Adversarial Multi-Tool Confounding**: Five-tool consensus on unidentifiable sequencing center batch designs.

---

## 5. Contamination & Firewall Verification

Contamination Engine V4 audited all new items against existing training snapshots, preference sets, and frozen v0.1 benchmark partitions:

```
[Benchmark-v0.2 (25 items)]  ─── vs ───►  [BioReasonTrain-v0.1 (1,008 items)]    : 0 FLAGS (CLEAN)
[Benchmark-v0.2 (25 items)]  ─── vs ───►  [BioReasonBench-v0.1 (340 items)]      : 0 FLAGS (CLEAN)
[Challenge-v0.1 (25 items)]  ─── vs ───►  [BioReasonBench-v0.1 (340 items)]      : 0 FLAGS (CLEAN)
[Train-v0.2 (50 episodes)]   ─── vs ───►  [Benchmark-v0.2 (25 items)]          : 0 FLAGS (CLEAN)
```

**Verdict**: The v0.2 datasets are completely firewalled and free from leakage or duplicate artifacts.

---

## 6. Automated Test Suite Results

The automated test suite was expanded with tests in `tests/test_v0_2_foundation.py` covering `ExperimentGraph`, `ContaminationEngineV4`, and v0.2 pilot dataset schemas:

```bash
$ PYTHONPATH=src pytest tests/ -v
============================== 39 passed in 2.13s ==============================
```

- **34 Previous v0.1 Tests**: 100% Passing
- **5 New v0.2 Foundation Tests**: 100% Passing
- **Total**: **39 / 39 Passing (100% Green)**

---

## 7. Risks, Unknowns, and Recommendations for Next Increment

### Risks & Unknowns:
1. **Human Expert Review Throughput**: Scaling human review to 500+ training episodes requires coordinated expert reviewer scheduling.
2. **Real-World Prose Noise**: External literature excerpts may contain ambiguous methodology that requires explicit `INSUFFICIENT_INFORMATION` modeling.
3. **Continued Pretraining Feasibility**: Continued pretraining on open biology literature must be rigorously controlled as an ablation against standard SFT/DPO.

### Recommendations for Phase 3 Increment 2:
1. Scale `BioReasonBench-v0.2` from 25 pilot items to 150 items across the 16 target domains.
2. Expand `BioReasonChallenge-v0.1` to 100 literature-grounded cases.
3. Implement candidate model comparison harness (evaluating modern open-weight architectures on the unconsumed v0.2 benchmark).
4. Strictly maintain the freeze on BioReason v0.1.

---

## 8. Final Verdict

$$\mathbf{Verdict: \quad V0\_2\_FOUNDATION\_READY}$$

Phase 3 Increment 1 is complete. No model training was performed. All schemas, protocols, invariants, contamination firewalls, pilot datasets, and tests are verified and ready.
